C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1986
12/31/1986	WO1986007609A1 VECTOR FOR THE EXPRESSION OF gamma-INTERFERON IN MAMMAL CELLS, METHOD FOR ITS IMPLEMENTATION, PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITION CONTAINING THE gamma-INTERFERON
12/31/1986	WO1986007595A1 Fibroblast growth factor
12/31/1986	WO1986007594A1 Protein purification
12/31/1986	WO1986007593A1 Methods and compositions useful in preventing equine influenza
12/30/1986	US4632981 Human antithrombin III
12/30/1986	US4632979 Therapeutic LHRH analogs
12/30/1986	US4632978 Cyclic polypeptides
12/30/1986	US4632780 N-terminal fragment of human pro-opiomelanocortin and process therefor
12/30/1986	EP0207044A1 Release of peptides from polypeptides
12/30/1986	EP0206942A1 DNA sequences of Archae bacteria, homologous to the v-myc oncogene, proteins encoded by these sequences, processes to obtain them and their immunological applications
12/30/1986	EP0206939A1 Expression of human IL-2 in mammalian cells by a recombined pox virus
12/30/1986	EP0206920A1 Expression vector for gamma interferon in cells of mammals, process for its use, product obtained and pharmaceutical composition containing gamma interferon
12/30/1986	EP0206863A1 Non-amidated derivatives of somatocrinine and process for the preparation by genetic engineering
12/30/1986	EP0206858A1 Process for the synthesis of macromolecular derivatives of nicotinamide adenine
12/30/1986	EP0206852A1 Conjugate constituted by a proteic surface adhesive of Streptococcus mutans, and by a polysaccharide of Streptococcus mutans, its preparation and its use, particularly in anti-caries vaccines
12/30/1986	EP0206849A2 Method for the diagnosis in vitro of malignant cells originating from the digestive duct
12/30/1986	EP0206842A1 Antigens related to the envelope glycoprotein of the acquired immunodeficiency syndrome virus
12/30/1986	EP0206828A2 Process for recovering refractile bodies containing heterologous proteins from microbial hosts and the use thereof
12/30/1986	EP0206801A2 Tissue-affinitive collagen for osteogenesis and method of producing the same
12/30/1986	EP0206783A2 Expression and secretion of polypeptides from saccharomyces cerevisiae
12/30/1986	EP0206769A2 A process for the production of alpha-human atrial natriuretic polypeptide
12/30/1986	EP0206733A1 Cloned human serum albumin gene
12/30/1986	EP0206730A2 Vasopressin antagonists
12/30/1986	EP0206719A2 Treatment fo autoimmune diseases such as rheumatoid arthritis with suppressor factor
12/30/1986	EP0206667A2 Derivatives of 4-desacetyl indole-dihydroindole alkaloids
12/30/1986	EP0206666A2 Hydrazide imide derivative of indole-dihydroindole alkaloids
12/30/1986	EP0206613A2 Activated bacillus thuringienses delta-endotoxin produced by an engineered hybrid gene
12/30/1986	EP0206533A2 Platelet inhibiting monoclonal antibody fragment
12/30/1986	EP0206532A2 Fibrinogen blocking monoclonal antibody
12/30/1986	EP0206448A1 Hemoglobin combined with a poly(alkylene oxide)
12/30/1986	EP0206400A1 New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
12/30/1986	EP0206200A2 Human cholinesterase-type proteins and their production
12/30/1986	EP0206118A2 Cyclic hexapeptide somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
12/30/1986	EP0206090A2 Peptide renin inhibitors
12/30/1986	EP0206045A1 Solvent-induced autolysis of cells
12/30/1986	EP0205715A1 DNA fragments, expression vectors, proteins, hosts, and process for production of the proteins
12/30/1986	EP0205625A1 Hepatitis b virus vaccine and process for its preparation
12/30/1986	EP0205574A1 Methods and compositions for the detection of familial hypercholesterolemia
12/30/1986	EP0205555A1 Serine protease inhibitors and methods for isolation of same.
12/30/1986	EP0205547A1 A compound and a composition for therapeutic or diagnostic use and the use of such compound and composition for therapeutic treatment and isolation of shigatoxine
12/30/1986	CA1215921A1 Method and means for microbial polypeptide expression
12/30/1986	CA1215920A1 Method of making a selected protein
12/30/1986	CA1215919A1 Detection of malignant tumor cells
12/30/1986	CA1215918A1 Suppressive factor of allergy
12/23/1986	US4631191 Polypeptide vaccine
12/23/1986	CA1215646A1 Method for producing liposomes
12/18/1986	WO1986007464A1 Methods for identifying alleles associated with increased risk of diabetes
12/18/1986	WO1986007384A1 Process for preparing hapatitis b virus surface antigen p31
12/18/1986	WO1986007383A1 Autoantigen vaccines
12/18/1986	WO1986007382A1 Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a
12/18/1986	WO1986007381A1 Monoclonal antibody to mhs-5: a new probe for sexual assault analyses
12/18/1986	WO1986007380A1 Process for preparing polypeptide
12/18/1986	WO1986007365A1 Products resulting from the conjugation of a macromolecular support, a hapten and a muramyl-peptide
12/17/1986	EP0205405A2 Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
12/17/1986	EP0205404A2 Hybrid interferons
12/17/1986	EP0205337A2 Chondrocyte antigens and monoclonal antibodies
12/17/1986	EP0205326A2 Antibody conjugates
12/17/1986	EP0205270A2 Radiolabeled antiplatelet monoclonal antibody for imaging in vivo thrombi
12/17/1986	EP0205046A2 Monoclonal antibody to human protein C
12/17/1986	EP0205038A1 Polypeptide, process for preparing it, microorganism and pharmaceutical use
12/17/1986	EP0204788A1 New hypocalcemic polypeptides, preparation thereof and drugs containing these active principles.
12/17/1986	EP0204775A1 Amino acid and peptide inhibitors of human leucocytic elastase
12/17/1986	EP0201413A1 Compounds causing the production of antibodies, immunogenic and immunoprotective compositions containing them, and process for obtaining antibodies by using them
12/17/1986	CN86104835A Vasopressin antagonists
12/17/1986	CN86103730A Removal of the n-terminal methionine from methionylproteins
12/17/1986	CN86100979A Process for the preparation malaria vaccine
12/16/1986	US4629783 Polypeptides
12/16/1986	US4629724 Amino acid ester and amide renin inhibitors
12/16/1986	US4629723 Potent thymopentin analogs
12/16/1986	US4629567 Alpha-1-antiprotease purification
12/16/1986	CA1215356A1 Process for the total or partial elimination of aspartic acid and glutamic acid from protein hydrolyzates and mixtures of aminoacids, and aminoacid compositions therefrom having high nutritive value
12/16/1986	CA1215337A1 Antitumor antibiotic
12/10/1986	EP0204680A2 Process for isolating and purifying the hepatitis B surface antigen
12/10/1986	EP0204590A2 T-DNA promoters of the Ri plasmid
12/10/1986	EP0204571A2 Selected difluoro derivatives
12/10/1986	EP0204566A2 Birth control vaccine
12/10/1986	EP0204527A1 Removal of the N-terminal methionine from methionylproteins
12/10/1986	EP0204522A2 Monoclonal antibody panel for histocompatibility typing
12/10/1986	EP0204480A2 Synthetic vaccines for foot and mouth disease
12/10/1986	EP0204401A1 Method of improving the yield of polypeptides produced in a host cell by stabilizing mRNA
12/10/1986	EP0204328A2 Novel THF compositions
12/10/1986	EP0204302A2 Laminin and the production thereof
12/10/1986	EP0203970A1 Transmissible, mammalian genes associated with tumor metastasis
12/09/1986	US4628043 Hypothalamic GRF agonists
12/09/1986	US4628032 Monoclonal antibody specific for a mammary tumor cytoplasmic antigen
12/09/1986	US4627982 Stimulating bone growth in mammals
12/04/1986	WO1986007090A1 Expression vector
12/04/1986	WO1986007063A1 Mutual separation of proteins
12/04/1986	WO1986007062A1 Monoclonal antibody to decay accelerating factor (daf), a method for making it, and use
12/04/1986	WO1986007060A1 Cloning and expression of host-protective immunogens of ibdv
12/03/1986	EP0203909A1 Early-summer meningo-encephalitis virus (FSME-virus) vaccine, and method of producing the same
12/03/1986	EP0203870A1 Coupling compounds, process for their preparation and their use as mediators in the development of the effects of interferons
12/03/1986	EP0203865A1 Process for the separation of antifactor VIII:C antibodies, especially for use in the blood plasma purification of a type A haemophiliac
12/03/1986	EP0203676A2 Vaccine for generating an immunogenic T cell response protective against a virus
12/03/1986	EP0203587A2 Ras oncogene peptides and antibodies
12/03/1986	EP0203552A2 Monoclonal antibodies for human non-small cell lung carcinomas
12/03/1986	EP0203463A2 Process for producing a material for affinity chromatography
12/03/1986	EP0203450A2 Derivatives of bicyclic amino acids process for their preparation, agents containing them and their use
12/03/1986	EP0203418A1 Oligopeptide derivatives, their preparation and their use as tensides with a good tolerance to the skin
12/03/1986	EP0203403A2 A cloned T cell capable of recognizing tumors and a T cell antigen receptor

1 ... 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 2874 2875 2876 2877 2878 ... 2916